|4Feb 5, 5:20 PM ET

AGARWAL SUNIL 4

4 · Sana Biotechnology, Inc. · Filed Feb 5, 2021

Insider Transaction Report

Form 4
Period: 2021-02-03
AGARWAL SUNIL
See Remarks
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-02-03+48,00048,000 total
    Exercise: $25.00Exp: 2031-02-02Common Stock (48,000 underlying)
Footnotes (1)
  • [F1]The option vests and becomes exercisable as to 25% of the underlying shares on February 15, 2022 and in 36 equal monthly installments thereafter.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION